Abstract
Purpose
The aim was to analyze the pregnancy and neonatal outcomes of pregnant women with new- onset acute myeloid leukemia (AML) diagnosed during pregnancy.
Methods
In this retrospective study 25 pregnant women who were diagnosed with new-onset AML during pregnancy from January 2010 to January 2021 were enrolled.
Results
A total of 4, 13 and 8 pregnant women with new-onset AML were diagnosed during the first, second, and third trimesters, respectively. Twelve of the 25 pregnant women underwent therapeutic abortion and 13 gave birth (9 preterm and 4 full-term newborns). The gestational age at initial clinical manifestations (13.4 ± 3.7 vs. 27.7 ± 5.6 weeks, P < 0.01) and diagnosis (16.9 ± 4.4 vs. 29.7 ± 5.5 weeks, P < 0.01) was lower in the pregnant women who underwent therapeutic abortion than in those who gave birth. Eighty-four percent (21/25) of the pregnant women with new-onset AML during pregnancy survived and were in remission and all the newborns were born alive. Three of the 13 newborns were exposed to chemotherapy, but no congenital malformations were observed. Eight newborns were admitted to the neonatal intensive care unit (NICU), and all recovered. The complete blood counts and biochemical examinations of the 8 newborns were normal.
Conclusions
New-onset AML during an earlier stage of pregnancy may increase the risk of poor pregnancy outcomes. The neonatal outcomes of pregnant women with new-onset AML during pregnancy are good with proper treatment.
Similar content being viewed by others
Heading
The dataset supporting the conclusions of this article is available in the clinical data repository of Peking University People's Hospital. Individual participant data were not shared. For the original data, please contact dingjingvv@126.com.
References
Salama M, Isachenko E, Ludwig S et al (2019) A successful multidisciplinary approach for treatment and for preserving the reproductive potential in a rare case of acute lymphocytic leukemia during pregnancy. Gynecol Endocrinol 35:115–118. https://doi.org/10.1080/09513590.2018.1498833
Wang P, Yang Z, Shan M et al (2021) Maternal and fetal outcomes of acute leukemia in pregnancy: a retrospective study of 52 patients. Front Oncol 11(5803994):2021. https://doi.org/10.3389/fonc.2021.803994.eCollection
Patel SJ, Ajebo G, Kota V et al (2020) Analysis of outcomes in hospitalized pregnant patients with acute myeloid leukemia. Am J Blood Res 10:68–75
Nolan S, Czuzoj-Shulman N, Abenhaim HA (2020) Obstetrical and newborn outcomes among women with acute leukemias in pregnancy: a population-based study. J Matern Fetal Neonatal Med 33:3514–3520. https://doi.org/10.1080/14767058.2019.1579188
Chang A, Patel S (2015) Treatment of acute myeloid leukemia during pregnancy. Ann Pharmacother 49(1):48–68. https://doi.org/10.1177/1060028014552516
Li YW, Xu YF, Hu W et al (2020) Acute myeloid leukemia during pregnancy: a single institutional experience with 17 patients and literature review. Int J Hematol 112:487–495. https://doi.org/10.1007/s12185-020-02938-2
Li H, Han C, Li K et al (2019) New onset acute promyelocytic leukemia during pregnancy: report of 2 cases. Cancer Biol Ther 20:397–401. https://doi.org/10.1080/15384047.2018.1529122
Kriouile M, Ameqrane F, Soradi H et al (2022) Acute myeloid leukemia and pregnancy about a case and review of the literature. Sch Int J Obstet Gynec 5:285–287. https://doi.org/10.36348/sijog.2022.v05i06.001
Chelghoum Y, Vey N, Raffoux E et al (2005) Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 104:110–117. https://doi.org/10.1002/cncr.21137
Zhu D, Tang D, Chai X et al (2021) Acute leukemia in pregnancy: a single institutional experience with 21 cases at 10 years and a review of the literature. Ann Med 53:567–575. https://doi.org/10.1080/07853890.2021.1908586
Thomas X (2015) Acute myeloid leukemia in the pregnant patient. Eur J Haematol 95:124–136. https://doi.org/10.1111/ejh.12479
Ali R, Ozkalemkaş F, Ozçelik T et al (2003) Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years. Leuk Res 27:381–385. https://doi.org/10.1016/s0145-2126(02)00182-0
Avivi I, Brenner B (2014) Management of acute myeloid leukemia during pregnancy. Future Oncol 10:1407–1415. https://doi.org/10.2217/fon.14.64
Shapira T, Pereg D, Lishner M (2008) How I treat acute and chronic leukemia in pregnancy. Blood Rev 22:247–259. https://doi.org/10.1016/j.blre.2008.03.006
Greenlund LJ, Letendre L, Tefferi A (2001) Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leuk Lymphoma 41:571–577. https://doi.org/10.3109/10428190109060347
Ali S, Jones GL, Culligan DJ et al (2015) Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy. Br J Haematol 170:487–495. https://doi.org/10.1111/bjh.13554
Milojkovic D, Apperley JF (2014) How I treat leukemia during pregnancy. Blood 123(7):974–984. https://doi.org/10.1182/blood-2013-08-283580
Fann RJ, D’Silv EC, Tanusha K et al (2023) Acute leukemia and lymphoma in pregnancy, a retrospective study from a tertiary center in Malaysia. Med J Malaysia 78:429–436
Luca A, Vinturache A, Ilea C et al (2022) Birth trauma in preterm spontaneous vaginal and cesarean section deliveries: a 10-years retrospective study. PLoS ONE 17(10):e0275726. https://doi.org/10.1371/journal.pone.0275726
Zahedi-Spung LD, Raghuraman N, Macones GA et al (2022) Neonatal morbidity and mortality by mode of delivery in very preterm neonates. Am J Obstet Gynecol 226(1):114.e1-114.e7. https://doi.org/10.1016/j.ajog.2021.07.013
Li S, Gao J, Liu J et al (2021) Incidence and risk factors for postpartum hemorrhage in China: a multicenter retrospective study. Front Med 8:673500. https://doi.org/10.3389/fmed.2021.673500
Erez O, Othman M, Rabinovich A et al (2022) DIC in pregnancy-pathophysiology, clinical characteristics, diagnostic scores, and treatments. J Blood Med 13:21–44. https://doi.org/10.2147/JBM.S273047
Henig I, Vidal L, Henig O et al (2013) Acute myeloid leukemia diagnosed during pregnancy: facing challenges. Systematic review and analysis of 174 reported cases. Blood 122:1421. https://doi.org/10.1182/blood.V122.21.1421.1421
Fracchiolla NS, Sciumè M, Dambrosi F et al (2017) Acute myeloid leukemia and pregnancy: clinical experience from a single center and a review of the literature. BMC Cancer 17:442. https://doi.org/10.1186/s12885-017-3436-9
Amit O, Barzilai M, Avivi I (2015) Management of hematologic malignancies: special considerations in pregnant women. Drugs 75:1725–1738. https://doi.org/10.1007/s40265-015-0464-0
Kayser S, Schlenk RF, Platzbecker U (2018) Management of patients with acute promyelocytic leukemia. Leukemia 32:1277–1294. https://doi.org/10.1038/s41375-018-0139-4
Valappil S, Kurkar M, Howell R (2007) Outcome of pregnancy in women treated with all-trans retinoic acid; a case report and review of literature. Hematology 12:415–418. https://doi.org/10.1080/10245330701448594
Sanz MA, Fenaux P, Tallman MS et al (2019) Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet. Blood 133:1630–1643. https://doi.org/10.1182/blood-2019-01-894980
Guo M, Lv J, Chen X et al (2022) Arsenic trioxide therapy during pregnancy: ATO and its metabolites in maternal blood and amniotic fluid of acute promyelocytic leukemia patients. Front Oncol 12(887026):2022. https://doi.org/10.3389/fonc.2022.887026.eCollection
Nowik CM, Gerrie AS, Wong J (2021) Conservative management of presumed fetal anemia secondary to maternal chemotherapy for acute myeloid leukemia. AJP Rep 11:e137–e141. https://doi.org/10.1055/S-0041-1740561
Siu BL, Alonzo MR, Vargo TA et al (2002) Transient dilated cardiomyopathy in a newborn exposed to idarubicin and all-trans-retinoic acid (ATRA) early in the second trimester of pregnancy. Int J Gynecol Cancer 12:399–402. https://doi.org/10.1046/j.1525-1438.2002.01128.x
Funding
This study was supported by the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics (2199000726).
Author information
Authors and Affiliations
Contributions
D: protocol/project development, data collection, data analysis, manuscript writing. X, F, L and H: data collection, data analysis. M: project development, manuscript editing. All authors contributed to the study conception and design. The first draft of the manuscript was written by Jing Ding and all authors commented on previous versions of the manuscript. All the authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee (EC) of the Peking University People’s Hospital.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ding, J., Xiao, Y., Fu, J. et al. Pregnancy and neonatal outcomes in 25 pregnant women diagnosed with new-onset acute myeloid leukemia during pregnancy. Arch Gynecol Obstet (2024). https://doi.org/10.1007/s00404-024-07402-8
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00404-024-07402-8